Investigation of the Effect of Faradarmani Consciousness Field on NF-κB and Proinflammatory Factors Genes Expression Using Blood Samples of Patients with COVID-19

The coronavirus disease 2019 (COVID-19) pandemic has become a worldwide challenge. Severe respiratory distress syndrome (ARDS) caused by coronavirus has often been associated with a cytokine storm. The Faradarmani Consciousness Field (CF), as one of many Taheri Consciousness Fields (TCFs) introduced by Mohammad Ali Taheri, is a novel field that is neither matter nor energy. Therefore, they are non-quantifiable and cannot be directly observed or measured; however, their effects can be demonstrated and measured through standard scientific experiments. The current study aimed to investigate the effect of Faradarmani CF on inflammatory factors in blood samples of patients with COVID-19. Blood samples were taken from 53 patients with COVID-19, and Faradarmani CF was applied to the blood samples of the treatment group. Then, the mRNA expression of NF-κB, TNF-α, IL-1β, and IL-6 genes was examined in the treated and control (non-treated) blood samples. The results indicated that under the influence of Faradarmani CF, the expression of NF-κB and IL-1β genes was significantly decreased (p<0.05), the TNF-α gene expression was significantly increased (p<0.05), but the expression of IL-6 did not show any significant change (p>0.05). We conclude that immunomodulation at the level of NF-κB and IL-1β by Faradarmani CF may inhibit the cytokine storm in COVID-19 patients. However, further studies are required to identify all effects of this T-Consciousness Field.